LCZ696

Novartis Heart Failure Drug Gains Speedy FDA Approval
Forbes
Tue, 07/7/15 - 07:14 pm
Novartis
heart failure
FDA
LCZ696
Entresto
Novartis' Summer Blockbuster LCZ696 Gains A Name, Skips An Advisory Panel
Forbes
Fri, 05/22/15 - 11:13 am
Novartis
LCZ696
Entresto
Novartis' 'megablockbuster' heart drug LCZ696 wins another rave preview
Fierce Biotech
Thu, 04/23/15 - 09:55 am
LCZ696
Novartis
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Opdivo, Praluent and LCZ-696 top a launch crop poised for $27B in sales
Fierce Pharma Marketing
Wed, 03/25/15 - 03:13 pm
drug launches
Opdivo
Bristol-Myers Squibb
Praluent
Sanofi
Regeneron
LCZ696
Novartis
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
Novartis looks to squelch neuro worries over its would-be cardio blockbuster
Fierce Biotech
Fri, 02/27/15 - 11:37 am
Novartis
LCZ696
New research: Could Novartis CVD game-changer increase dementia risk?
BioPharma Dive
Wed, 02/11/15 - 08:58 am
Novartis
LCZ696
New Heart Drug From Novartis: Will It Raise The Risk of Alzheimer's Disease?
Forbes
Mon, 02/9/15 - 10:39 am
Novartis
Alzheimer's disease
LCZ696
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
Novartis says heart-failure drug wins faster review in Europe
Yahoo/Reuters
Sat, 11/29/14 - 10:30 am
Novartis
heart failure
Europe
LCZ696
How to prep for a 'megablockbuster' launch? Novartis lines up cost-savings data
Fierce Pharma Marketing
Thu, 11/20/14 - 10:51 am
Novartis
LCZ696
drug launches
Novartis' Drug Could Change Course of Heart Failure for Patients
Drug Discovery and Development
Tue, 11/18/14 - 10:37 am
Novartis
LCZ696
heart failure
Novartis chief says new heart failure drug will be a winner
Seeking Alpha
Tue, 10/28/14 - 09:48 am
Novartis
Joe Jimenez
heart failure
LCZ696
Blockbusters Differentiate Novartis
Morningstar
Fri, 09/5/14 - 07:53 am
Novartis
LCZ696
Doctors urge caution on Novartis' heart failure drug
Pharmaphorum
Thu, 09/4/14 - 08:06 am
Novartis
heart failure
LCZ696
Novartis' Game Changer: When Failure Turns To Success
Forbes
Tue, 09/2/14 - 08:25 am
Novartis
heart failure
LCZ696
Novartis drug could be breakthrough in heart failure
Pharmaforum
Mon, 09/1/14 - 03:15 pm
Novartis
heart failure
LCZ696
Novartis Rises Most in Five Months on Heart-Drug Trial
Bloomberg
Mon, 09/1/14 - 09:42 am
Novartis
LCZ696
heart failure

Pages